论文信息 - Brentuximab vedotin as a bridge to allogeneic stem-cell transplantation for refractory or relapsing patients with CD30 positive anaplastic or T-cell non-Hodgkin lymphomas: a study on behalf of the SFGM-TC - 字舞流文

Brentuximab vedotin as a bridge to allogeneic stem-cell transplantation for refractory or relapsing patients with CD30 positive anaplastic or T-cell non-Hodgkin lymphomas: a study on behalf of the SFGM-TC

R. Bouabdallah | L. Biard | G. Socié | P. Brice | D. Sibon | C. Tomowiak | J. Cornillon | A. de Masson | A. Charbonnier | M. Mercier | R. D. de Latour | S. Nimubona | H. Labussière-Wallet | C. Borel | S. Garciaz | F. S. de Fontbrune | O. Cassuto | J. Delage | H. Labussière‐Wallet | M. Loschi | Mickael Loschi